S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
OTCMKTS:CNBX

CNBX Pharmaceuticals Stock Competitors

$7.35
+0.04 (+0.55%)
(As of 05/20/2022 12:00 AM ET)
Add
Compare
Today's Range
$7.35
$7.35
50-Day Range
$6.76
$10.56
52-Week Range
$0.06
$0.23
Volume
360 shs
Average Volume
106,408 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A

CNBX Pharmaceuticals (OTCMKTS:CNBX) Vs. IIPR, MSRT, GRWG, XXII, KSHB, NSAV, CANN, TRTC, PVSP, and NMUS

Should you be buying CNBX Pharmaceuticals stock or one of its competitors? The main competitors of CNBX Pharmaceuticals include Innovative Industrial Properties (IIPR), MassRoots (MSRT), GrowGeneration (GRWG), 22nd Century Group (XXII), KushCo (KSHB), Net Savings Link (NSAV), General Cannabis (CANN), Unrivaled Brands (TRTC), Pervasip (PVSP), and Nemus Bioscience (NMUS). These companies are all part of the "cannabis" industry.

CNBX Pharmaceuticals vs.

Innovative Industrial Properties (NYSE:IIPR) and CNBX Pharmaceuticals (OTCMKTS:CNBX) are both finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, profitability, valuation, risk, community ranking, dividends and earnings.

Innovative Industrial Properties received 183 more outperform votes than CNBX Pharmaceuticals when rated by MarketBeat users. Likewise, 61.97% of users gave Innovative Industrial Properties an outperform vote while only 60.26% of users gave CNBX Pharmaceuticals an outperform vote.

CompanyUnderperformOutperform
Innovative Industrial PropertiesOutperform Votes
277
61.97%
Underperform Votes
170
38.03%
CNBX PharmaceuticalsOutperform Votes
94
60.26%
Underperform Votes
62
39.74%

Innovative Industrial Properties has a net margin of 54.43% compared to CNBX Pharmaceuticals' net margin of 0.00%. Innovative Industrial Properties' return on equity of 7.91% beat CNBX Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Innovative Industrial Properties 54.43% 7.91% 5.87%
CNBX Pharmaceuticals N/A N/A N/A

66.9% of Innovative Industrial Properties shares are held by institutional investors. 1.5% of Innovative Industrial Properties shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Innovative Industrial Properties had 7 more articles in the media than CNBX Pharmaceuticals. MarketBeat recorded 8 mentions for Innovative Industrial Properties and 1 mentions for CNBX Pharmaceuticals. Innovative Industrial Properties' average media sentiment score of 0.60 beat CNBX Pharmaceuticals' score of 0.00 indicating that Innovative Industrial Properties is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Innovative Industrial Properties
2 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
CNBX Pharmaceuticals
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Innovative Industrial Properties has higher revenue and earnings than CNBX Pharmaceuticals.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Innovative Industrial Properties$204.55 million17.94$113.99 million$4.8327.17
CNBX PharmaceuticalsN/AN/AN/AN/AN/A

Innovative Industrial Properties presently has a consensus price target of $257.33, suggesting a potential upside of 96.12%. Given Innovative Industrial Properties' higher possible upside, analysts plainly believe Innovative Industrial Properties is more favorable than CNBX Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Innovative Industrial Properties
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00
CNBX Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Summary

Innovative Industrial Properties beats CNBX Pharmaceuticals on 12 of the 12 factors compared between the two stocks.


New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CNBX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of OTCMKTS and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CNBX Pharmaceuticals (OTCMKTS:CNBX) vs. Its Competitors

MetricCNBX PharmaceuticalsBiotechnology IndustryMedical SectorOTCMKTS Exchange
Market CapN/A$212.87M$4.32B$6.86B
Dividend YieldN/A1.38%2.02%37.21%
P/E RatioN/A8.669.071.96
Price / SalesN/A6,976.672,413.071,322.85
Price / CashN/A13.3422.9225.99
Price / BookN/A5.274.034.22
Net IncomeN/AN/A$164.30M$721.83M
7 Day Performance8.73%-0.28%1.10%0.77%
1 Month Performance-25.30%-9.30%-14.06%-5.48%
1 Year Performance-67.76%11.81%-31.00%51.41%

CNBX Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IIPR
Innovative Industrial Properties
3.0681 of 5 stars
$131.21
+0.8%
$257.33
+96.1%
-24.9%$3.67B$204.55M27.1718Short Interest ↑
MSRT
MassRoots
1 of 5 stars
$5.20
-0.2%
N/A-37.0%$2.60B$10K0.003News Coverage
Gap Up
GRWG
GrowGeneration
1.9926 of 5 stars
$5.06
-4.0%
$16.31
+222.4%
-87.0%$320.12M$422.49M253.00634
XXII
22nd Century Group
1.7581 of 5 stars
$1.79
+1.7%
$6.50
+263.1%
N/A$289.58M$30.95M-7.7876Positive News
Gap Up
KSHB
KushCo
1.7731 of 5 stars
$0.70
flat
$2.00
+187.8%
-20.1%$110.83M$113.84M-3.86109Gap Down
High Trading Volume
NSAV
Net Savings Link
0.6665 of 5 stars
$0.01
flat
N/A+9.1%$58.63MN/A0.001News Coverage
Positive News
CANN
General Cannabis
1.1598 of 5 stars
$0.29
-5.6%
N/A-58.8%$28.11M$5.93M0.0077Gap Up
TRTC
Unrivaled Brands
1.0581 of 5 stars
$0.09
flat
N/A-61.0%$20.16M$14.29M0.0050
PVSP
Pervasip
0.7465 of 5 stars
$0.00
-9.5%
N/A-55.8%$10.82MN/A0.003Positive News
Gap Down
NMUS
Nemus Bioscience
1 of 5 stars
$0.05
flat
N/A-64.6%$6.03MN/A0.00N/AGap Down
LBUY
Leafbuyer Technologies
1.2664 of 5 stars
$0.05
flat
N/A-59.2%$4.71M$2.67M-1.3329Positive News
Gap Down
CNAB
United Cannabis
0.7998 of 5 stars
N/AN/AN/A$1.55MN/A0.0065News Coverage
Gap Down
High Trading Volume
DIGP
Digipath
1.0464 of 5 stars
$0.02
+1.1%
N/A-54.8%$1.44M$2.50M0.0017Gap Down
MNTR
Mentor Capital
1.3115 of 5 stars
$0.05
-7.4%
N/A-54.5%$1.24M$6.01M-5.0073Positive News
Gap Down
FWDG
FutureWorld
0.8531 of 5 stars
N/AN/AN/A$880KN/A0.008
GRWC
Grow Capital
1.1598 of 5 stars
$0.00
flat
N/AN/A$50K$2.37M0.0021News Coverage
OPMZ
1PM Industries
0.8265 of 5 stars
N/AN/AN/A$0.00N/A0.002
AQSP
Acquired Sales
0.8265 of 5 stars
$3.71
flat
N/A-18.5%$0.00N/A0.0046News Coverage
AMMJ
American Cannabis
0.9064 of 5 stars
$0.06
+0.2%
N/A-71.4%$0.00N/A0.009Gap Down
ACAN
AmeriCann
0.7998 of 5 stars
$0.37
0.0%
N/A-67.3%$0.00N/A0.003Positive News
Gap Down
CBDS
Cannabis Sativa
0.8798 of 5 stars
$0.13
-7.1%
N/A-73.8%$0.00N/A0.0012
CRWG
CrowdGather
1.2664 of 5 stars
$0.01
flat
N/A-48.7%$0.00N/A0.003Gap Up
High Trading Volume
FRLF
Freedom Leaf
0.9064 of 5 stars
N/AN/AN/A$0.00N/A0.0012Gap Up
FUTL
FutureLand
0.7731 of 5 stars
N/AN/AN/A$0.00N/A0.003
GBLX
GB Sciences
0.8798 of 5 stars
$0.03
flat
N/A-40.4%$0.00N/A0.0016News Coverage
Gap Down
GRNH
GreenGro Technologies
0.9598 of 5 stars
$0.01
flat
N/A-69.9%$0.00N/A0.00N/AGap Down
HRVSF
Harvest Health & Recreation
1 of 5 stars
$3.22
flat
N/A-22.4%$0.00N/A0.001,200Gap Down
MCOA
Marijuana Company of America
0.9331 of 5 stars
$0.00
+14.3%
N/A-85.7%$0.00N/A0.004
MJNA
Medical Marijuana
0.9864 of 5 stars
$0.02
-0.6%
N/A-60.2%$0.00N/A0.0091Upcoming Earnings
News Coverage
MDCN
Medican Enterprises
0.9598 of 5 stars
$0.00
-50.0%
N/A-90.0%$0.00N/A0.003News Coverage
MDCL
Medicine Man Technologies
0.9331 of 5 stars
$1.42
-2.7%
N/A-43.8%$0.00N/A0.0025
NCAP
Northsight Capital
0.8798 of 5 stars
N/AN/AN/A$0.00N/A0.003Gap Up
NGBL
Notis Global
0.9064 of 5 stars
N/AN/AN/A$0.00N/A0.00N/AGap Up
High Trading Volume
OWCP
OWC Pharmaceutical Research
0.9864 of 5 stars
$0.00
-50.0%
N/A-98.9%$0.00N/A0.009
PKPH
Peak Pharmaceuticals
1 of 5 stars
$0.06
-17.0%
N/A-49.1%$0.00N/A0.001Gap Up
SRNA
Surna
0.9864 of 5 stars
$1.04
-9.6%
N/A+1,603.7%$0.00N/A0.0027Gap Up
MJLB
Ultrack Systems
0.9864 of 5 stars
$0.02
-3.7%
N/A-66.3%$0.00N/A0.0018Gap Down
BUDZ
WEED
1 of 5 stars
$0.18
-2.7%
N/A-56.9%$0.00N/A0.002Short Interest ↑
ZDPY
Zoned Properties
0.9864 of 5 stars
$0.76
-5.0%
N/A+31.7%$0.00N/A0.004Gap Down
ZZLL
ZZLL Information Technology
0.7998 of 5 stars
$0.50
-18.0%
N/A+354.5%$0.00N/A0.0020Gap Down
This page was last updated on 5/21/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.